Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity
Naoto Kubota, Tetsuya Kubota, Eiji Kajiwara, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Mechanisms of Insulin Action and Insulin Resistance
Max C. Petersen, Gerald I. Shulman
Physiological Reviews (2018) Vol. 98, Iss. 4, pp. 2133-2223
Open Access | Times Cited: 2211
The PI3K/AKT pathway in obesity and type 2 diabetes
Xingjun Huang, Guihua Liu, Jiao Guo, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 11, pp. 1483-1496
Open Access | Times Cited: 1219
SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology
Hitoshi Shimano, Ryuichiro Sato
Nature Reviews Endocrinology (2017) Vol. 13, Iss. 12, pp. 710-730
Closed Access | Times Cited: 904
Biochemical and cellular properties of insulin receptor signalling
Rebecca A. Haeusler, Timothy E. McGraw, Domenico Accili
Nature Reviews Molecular Cell Biology (2017) Vol. 19, Iss. 1, pp. 31-44
Open Access | Times Cited: 617
Pathophysiology of Diabetic Dyslipidemia
Tsutomu Hirano
Journal of Atherosclerosis and Thrombosis (2018) Vol. 25, Iss. 9, pp. 771-782
Open Access | Times Cited: 415
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Sevgican Demir, Peter P. Nawroth, Stephan Herzig, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 325
Role of Insulin Resistance in MAFLD
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4156-4156
Open Access | Times Cited: 284
Resolving the Paradox of Hepatic Insulin Resistance
Dominic Santoleri, Paul M. Titchenell
Cellular and Molecular Gastroenterology and Hepatology (2018) Vol. 7, Iss. 2, pp. 447-456
Open Access | Times Cited: 254
Obesity and ageing: Two sides of the same coin
Bjorn T. Tam, José A. Morais, Sylvia Santosa
Obesity Reviews (2020) Vol. 21, Iss. 4
Closed Access | Times Cited: 173
Hepatic lipid droplet homeostasis and fatty liver disease
Fabian Seebacher, Anja Zeigerer, Nora Kory, et al.
Seminars in Cell and Developmental Biology (2020) Vol. 108, pp. 72-81
Closed Access | Times Cited: 144
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Jesús Burillo, Patricia Marqués, Beatriz Jiménez, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1236-1236
Open Access | Times Cited: 135
Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease
Zixi Wang, Shijia Zhu, Yuemeng Jia, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1968-1984.e20
Open Access | Times Cited: 43
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
Tao Bo, Ling Gao, Zhenyu Yao, et al.
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 947-968
Closed Access | Times Cited: 27
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Chenglin Hu, Yuan Chen, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway
Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki
Cell Metabolism (2017) Vol. 25, Iss. 4, pp. 797-810
Open Access | Times Cited: 146
PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin
Aurèle Besse‐Patin, Stewart Jeromson, Philipa Levesque-Damphousse, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 10, pp. 4285-4290
Open Access | Times Cited: 105
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Midori Honma, Shojiro Sawada, Yoshiyuki Ueno, et al.
International Journal of Obesity (2018) Vol. 42, Iss. 9, pp. 1544-1555
Open Access | Times Cited: 91
Hepatic transcriptional responses to fasting and feeding
Lara Bideyan, Rohith T. Nagari, Peter Tontonoz
Genes & Development (2021) Vol. 35, Iss. 9-10, pp. 635-657
Open Access | Times Cited: 75
The Influence of Different Types of Diabetes on Vascular Complications
Jiahua Wei, Jiaxing Tian, Cheng Tang, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 46
The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets
Rana Taheri, Yazdan Mokhtari, Amir‐Mohammad Yousefi, et al.
Cell Biology International (2024) Vol. 48, Iss. 8, pp. 1049-1068
Closed Access | Times Cited: 15
Airborne Nanoplastics Exposure Inducing Irreversible Glucose Increase and Complete Hepatic Insulin Resistance
Ziye Yang, Huajiang Dong, Yifei Gao, et al.
Environmental Science & Technology (2024)
Closed Access | Times Cited: 11
Identification of novel peptides from goat milk casein that ameliorate high-glucose-induced insulin resistance in HepG2 cells
Han Gong, Jiaqian Gao, Yi Wang, et al.
Journal of Dairy Science (2020) Vol. 103, Iss. 6, pp. 4907-4918
Open Access | Times Cited: 63
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
Kasper W. ter Horst, Daniel F. Vatner, Dongyan Zhang, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 489-498
Open Access | Times Cited: 60
TFEB is a central regulator of the aging process and age-related diseases
Samuel Abokyi, George Ghartey‐Kwansah, Dennis Y. Tse
Ageing Research Reviews (2023) Vol. 89, pp. 101985-101985
Open Access | Times Cited: 22
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 42-53
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top